Skip to content 
Achilles pain can range from a nagging overuse injury to a complete tendon rupture.
Those are not the same condition, and they should not be treated as though they are.
Mesenchymal stromal cells, or MSCs, have been studied for tendon injuries because of their potential effects on cellular signaling, inflammation, and tissue remodeling. But human research specifically involving the Achilles tendon is still limited.
A small 2024 human study of MSC injections for chronic Achilles tendinopathy reported encouraging safety and symptom findings, but it included only 10 patients and did not have a placebo control group. (PubMed)
So while regenerative treatment may be worth discussing in selected chronic tendon cases, it should not be presented as a proven replacement for rehabilitation or appropriate surgical care.
Table of Contents
Quick Answer: Can Stem Cells Help an Achilles Tendon Injury?
Possibly, depending on the injury.
The strongest human stem-cell evidence currently involves chronic Achilles tendinopathy, not a completely ruptured tendon.
Early studies suggest MSC-based treatments may be feasible and warrant additional research, but larger randomized controlled trials are still needed. (PubMed)
For a complete acute Achilles rupture, the treatment discussion is different.
Modern evidence supports both surgical and appropriately managed nonsurgical treatment for selected ruptures. A large randomized trial involving more than 500 patients found similar overall functional outcomes at 12 months among nonsurgical treatment, open repair, and minimally invasive surgery, although rerupture occurred more often in the nonsurgical group. (PubMed)
A regenerative injection should therefore not delay appropriate orthopedic evaluation of a suspected rupture.
Achilles Tendinopathy vs Achilles Tendon Rupture
This is the most important distinction.
Achilles Tendinopathy
Achilles tendinopathy is usually a chronic overuse condition.
Common symptoms include:
- Pain with running or jumping
- Morning stiffness
- Tenderness
- Thickening of the tendon
- Pain that worsens with activity
- Reduced ability to tolerate exercise
The 2024 clinical practice guideline for midportion Achilles tendinopathy emphasizes diagnosis, load management, and physical-therapy interventions. (PubMed)
Achilles Tendon Rupture
A rupture is a structural tear of the tendon.
Patients may describe:
- A sudden pop
- Feeling as though someone kicked the back of the ankle
- Immediate weakness
- Difficulty pushing off
- Difficulty standing on the toes
- Sudden swelling or bruising
A complete rupture requires prompt medical evaluation because surgical and nonsurgical treatment decisions depend on the individual injury.
What Does the Human Stem Cell Research Show?
Human clinical evidence specifically involving the Achilles tendon is still relatively small.
Chronic Achilles Tendinopathy
In 2024, researchers published the results of a phase IIa study involving 10 patients with chronic non-insertional Achilles tendinopathy.
All participants had experienced pain and swelling for more than six months and had already failed conservative treatment.
Researchers:
- Collected the patients’ own bone marrow
- Isolated and culture-expanded MSCs
- Injected approximately 5 to 19 million autologous MSCs into the affected Achilles tendon under ultrasound guidance
At 24 weeks:
- No serious adverse reactions were reported
- Pain scores improved
- VISA-A scores improved
- Several other patient-reported outcomes improved
- Ultrasound showed a small reduction in tendon thickness
The investigators concluded that the study demonstrated initial safety and proof of concept and supported proceeding to a larger randomized trial. (PubMed)
That last part is important.
This was not proof that stem cells are an established treatment for Achilles tendinopathy.
There were only 10 patients.
There was no placebo group.
And the treatment used autologous culture-expanded bone-marrow MSCs, which is not the same product as every other stem-cell treatment offered in regenerative medicine.
What About Stem Cells for an Achilles Rupture?
There is even less clinical evidence here.
A small 2024 human study evaluated adipose-derived stem cells in patients with acute Achilles ruptures.
Only 15 patients were included across treatment groups, and researchers reported better functional scores in the cell-treatment group. (PubMed)
That is interesting preliminary research.
But 15 patients is far too small to conclude that stem-cell therapy should replace established rupture management.
Another preliminary study evaluated microfragmented adipose tissue as an adjunct to surgical Achilles repair, rather than as an alternative to surgery. (PubMed)
That distinction matters:
Using a biologic during a surgical repair is not evidence that an injection alone can reconnect a completely ruptured Achilles tendon.
Can Stem Cells Reconnect a Completely Torn Achilles Tendon?
That should not be promised.
A completely ruptured Achilles creates a mechanical disruption between tendon ends.
A cell injection should not be assumed to:
- Pull separated tendon ends back together
- Restore normal tendon tension
- Reconstruct a large tendon gap
- Replace rehabilitation
- Eliminate the need for surgery in every patient
Some acute Achilles ruptures can be successfully treated without surgery, but that involves structured orthopedic management and rehabilitation rather than simply injecting the tendon and waiting.
Does Every Achilles Rupture Need Surgery?
No.
This is another area where older assumptions have changed.
A large 2022 randomized controlled trial compared:
- Nonoperative treatment
- Open surgical repair
- Minimally invasive repair
among 554 patients with acute Achilles rupture.
At 12 months, overall functional outcomes were similar between the three groups.
However, rerupture occurred in:
- 6.2% of the nonsurgical group
- 0.6% of the open-surgery group
- 0.6% of the minimally invasive group
Surgical treatment also introduced different complications, including nerve injuries. (PubMed)
A more recent meta-analysis likewise found that surgery reduced rerupture risk but increased other complications. (PubMed)
So the correct question is not:
“Is surgery bad?”
or
“Can stem cells replace surgery?”
It is:
“Which treatment makes the most sense for this rupture, this patient, and these functional goals?”
What Is the First-Line Treatment for Achilles Tendinopathy?
For chronic Achilles tendinopathy, rehabilitation remains central.
A 2026 systematic review found the strongest evidence for exercise-based rehabilitation and progressive tendon loading, while evidence supporting many medical interventions and adjunct treatments remained limited. (PubMed)
That means regenerative treatment should generally not be discussed as a substitute for appropriately designed tendon rehabilitation.
A good treatment plan may involve:
- Progressive loading exercises
- Activity modification
- Physical therapy
- Evaluation of biomechanics
- Gradual return to sport
- Other treatments when appropriate
A patient who has never attempted appropriate rehabilitation may have a very different treatment plan from someone who has had persistent symptoms despite six months or more of well-designed conservative care.
When Might Someone Consider a Regenerative Evaluation?
A regenerative consultation may be reasonable to discuss when someone has:
- Chronic Achilles tendinopathy
- Persistent pain despite appropriate rehabilitation
- Tendon degeneration confirmed on examination or imaging
- Difficulty returning to normal activity
- A desire to understand nonsurgical options
That does not mean every patient in these categories should receive stem-cell treatment.
The limited human evidence means expectations should remain realistic.
When Should You See an Orthopedic Specialist?
Prompt orthopedic evaluation is particularly important if you have:
- A sudden pop in the Achilles
- Inability to push off normally
- Difficulty standing on the affected toes
- A suspected complete rupture
- Significant weakness after an acute injury
- A palpable defect in the tendon
- Recurrent injury
- Failure of appropriate conservative treatment
Regenerative treatment should never delay diagnosis of a significant structural injury.
Does the Type of Stem Cell Matter?
Yes.
The limited Achilles research illustrates this perfectly.
Studies have involved:
- Autologous bone-marrow-derived MSCs
- Adipose-derived cells
- Microfragmented adipose tissue
The Re/ Clinic uses umbilical cord-derived regenerative products.
These are not interchangeable products.
Research involving one cell source can help explain the broader scientific rationale for tendon regeneration research, but it cannot automatically prove that another product will produce the same clinical result.
This is why patients should ask:
What exact product was used in the study?
and:
Is that the same product being offered to me?
Frequently Asked Questions
Can stem cells help Achilles tendinopathy?
Early human research suggests MSC therapy may warrant further investigation for chronic Achilles tendinopathy.
A 2024 phase IIa study involving 10 patients reported improvements in pain and function without serious adverse reactions, but it lacked a control group and was designed primarily as an early proof-of-concept study. (PubMed)
Larger randomized trials are needed.
Can stem cells fix a completely torn Achilles tendon?
There is not sufficient evidence to say that a stem-cell injection can reconnect and restore a completely ruptured Achilles tendon.
Complete ruptures should receive appropriate orthopedic evaluation.
Can an Achilles rupture heal without surgery?
Yes, selected acute Achilles ruptures can be managed nonsurgically with structured functional rehabilitation.
A large randomized trial found similar overall 12-month functional outcomes between surgical and nonsurgical management, although rerupture occurred more often after nonsurgical treatment. (PubMed)
Is surgery always better for an Achilles rupture?
No.
Surgery lowers rerupture risk but also introduces surgical complications.
Treatment should be individualized based on the injury, age, activity level, goals, and clinical circumstances. (PubMed)
What is the best treatment for Achilles tendinopathy?
Progressive exercise-based rehabilitation currently has the strongest evidence as a first-line treatment for chronic Achilles tendinopathy. (PubMed)
What if physical therapy has not worked?
Persistent symptoms despite well-designed rehabilitation may justify reassessment of:
- The diagnosis
- Loading program
- Imaging
- Other contributing factors
- Additional treatment options
That may include discussion of regenerative medicine in selected cases.
Are stem cells FDA-approved for Achilles tendon injuries?
No stem-cell product is currently FDA-approved specifically for Achilles tendinopathy or Achilles tendon rupture.
FDA identifies tendonitis and other orthopedic conditions among uses for which regenerative medicine therapies have not been approved. (U.S. Food and Drug Administration)
The Diagnosis Comes First
Achilles pain does not automatically mean the same treatment for everyone.
Chronic tendinopathy is different from an acute rupture.
A partial injury is different from a complete structural disruption.
And an athlete trying to return to competitive sport may have different priorities from someone whose primary goal is walking without pain.
At The Re/ Clinic in Sandy, Utah, regenerative consultations can include review of symptoms, previous treatment, imaging when appropriate, and whether a regenerative approach is reasonable to discuss.
The goal should not be to force every Achilles injury into a stem-cell treatment.
It should be to understand what is actually wrong with the tendon and what options make sense for that specific injury.
Call: 385-240-1000
Location: 9035 S 700 E, Sandy, UT 84070 (The Re/ Clinic)
References
- Autologous bone marrow derived mesenchymal stem cells are safe for the treatment of Achilles tendinopathy. 2024. Phase IIa human proof-of-concept study involving 10 patients with chronic Achilles tendinopathy. (PubMed)
- Autologous Stem Cells in Achilles Tendinopathy (ASCAT). Protocol for the phase IIa study evaluating culture-expanded autologous bone-marrow MSCs in chronic midportion Achilles tendinopathy. (PubMed)
- Effect of cell therapy with adipose-derived stem cells in the treatment of acute rupture of the Achilles tendon in humans. 2024. Small preliminary human study involving 15 patients. (PubMed)
- Myhrvold SB, et al. Nonoperative or Surgical Treatment of Acute Achilles’ Tendon Rupture. New England Journal of Medicine. 2022. Large randomized trial comparing nonsurgical treatment, open repair, and minimally invasive repair. (PubMed)
- Achilles Pain, Stiffness, and Muscle Power Deficits: Midportion Achilles Tendinopathy Revision. Journal of Orthopaedic & Sports Physical Therapy. 2024 clinical practice guideline. (PubMed)
- UK defence rehabilitation review of Achilles and patellar tendinopathy conservative management. 2026. Systematic review identifying exercise-based rehabilitation as the intervention with the strongest evidence. (PubMed)
- U.S. Food and Drug Administration. Important Patient and Consumer Information About Regenerative Medicine Therapies. FDA states that regenerative medicine therapies have not been approved for orthopedic indications including tendonitis. (U.S. Food and Drug Administration)
- Utah Code § 58-1-512. Current stem-cell disclosure requirements effective May 6, 2026. (Utah Legislature)
Utah Stem Cell Therapy Notice
THIS NOTICE MUST BE PROVIDED TO YOU UNDER UTAH LAW.
This health care practitioner performs one or more stem cell therapies that have not yet been approved by the United States Food and Drug Administration.
You are encouraged to consult with your primary care provider before undergoing a stem cell therapy. (Utah Legislature).